# Brand Designer

- **Company:** Neros Technologies
- **Location:** Torrance, California, United States
- **Workplace:** Workplace not stated
- **Salary:** USD 111K–155K / year
- **Seniority:** Senior
- **Role:** Marketing and communications
- **Countries:** United States
- **Posted:** 2026-10-28
- **Key facts:** Tools: Figma, Illustrator, Photoshop, InDesign; Experience: 5+ years; Equity
- **Job page:** https://rolefalcon.com/job/51393518-brand-designer-neros-technologies-torrance

Brand Designer is an open role at Neros Technologies, a company in aerospace and defense. The job is based in Torrance, United States. Our labels mark it as a senior-level role in marketing and communications. It asks for 5+ years of experience. Perks named in the posting: equity. Neros Technologies has 27 open positions on this site, 6 of them in IT and engineering.

To apply, open the job page above and follow its Apply link to the original posting.

## Similar jobs

- [Founding Growth and Content Marketer](https://rolefalcon.com/job/51992786-founding-growth-and-content-marketer-themuralgroup-new-york) — themuralgroup
- [Senior Manager, Content Marketing](https://rolefalcon.com/job/51976543-senior-manager-content-marketing-cogent-security-remote) — Cogent Security
- [Director of Content Marketing](https://rolefalcon.com/job/51976542-director-of-content-marketing-cogent-security-remote) — Cogent Security
- [Director of Communications](https://rolefalcon.com/job/51976541-director-of-communications-cogent-security-remote) — Cogent Security
- [Sr. Product Marketing Manager](https://rolefalcon.com/job/51327616-sr-product-marketing-manager-cogent-security-remote) — Cogent Security
- [Content Lead](https://rolefalcon.com/job/51984830-content-lead-titan-new-york) — Titan
- [Marketing Lead](https://rolefalcon.com/job/51141519-marketing-lead-blueprint-technologies-bellevue) — Blueprint Technologies
- [Senior Marketing Manager, Skeletal Dysplasia](https://rolefalcon.com/job/50998072-senior-marketing-manager-skeletal-dysplasia-bridgebio-pharma-hybrid-san) — BridgeBio Pharma